Acute Leukemias


Twenty-one adult patients with acute mye-<lb>loid leukemia (AML) were treated with the<lb>EORTC LAM-6 remission induction pro-<lb>tocol [daunorubicin (DNR) (45 mg/m2 ,<lb>days 1-3), cytarabine (200 mg/m2 ,<lb>days 1-7)<lb>and vincristine (1 mg/m2 ,<lb>day 2)]. Pharma-<lb>cokinetics of DNR were studied at day 1.<lb>The concentration of DNR and daunorubi-<lb… (More)
DOI: 10.1007/978-3-642-71213-5


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics